Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 2312 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2000Detection of bile reflux: in vivo validation of the Bilitec fibreoptic systemBarrett, M.; Myers, J.; Watson, D.; Jamieson, G.
2014Clinical importance of incidental findings reported on small-volume dental cone beam computed tomography scans focused on impacted maxillary canine teethDoğramacı, E.; Rossi-Fedele, G.; McDonald, F.
2016Factors associated with disability in rural Bangladesh: Bangladesh population-based diabetes and eye study (BPDES)Islam, F.; Bhowmik, J.; Islam, S.; Renzaho, A.; Hiller, J.; Federici, S.
2016Visual cues of object properties differentially affect anticipatory planning of digit forces and placementLee-Miller, T.; Marneweck, M.; Santello, M.; Gordon, A.
2014A randomized, controlled trial of negative pressure wound therapy of pressure ulcers via a novel polyurethane foamWagstaff, M.; Driver, S.; Coghlan, P.; Greenwood, J.
2017Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosisMcPherson, S.; Hardy, T.; Dufour, J.; Petta, S.; Romero-Gomez, M.; Allison, M.; Oliveira, C.; Francque, S.; van Gaal, L.; Schattenberg, J.; Tiniakos, D.; Burt, A.; Bugianesi, E.; Ratziu, V.; Day, C.; Anstee, Q.
2009Donor Mannose - Binding Lectin Deficiency Increases the Likelihood of Clinically Significant Infection after Liver TransplantationWorthley, D.; Johnson, D.; Eisen, D.; Dean, M.; Heatley, S.; Tung, J.; Scott, J.; Padbury, R.; Harley, H.; Bardy, P.; Angus, P.; Mullighan, C.
2017CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressorsHughes, A.; Clarson, J.; Tang, C.; Vidovic, L.; White, D.; Hughes, T.; Yong, A.
2016The long-term psychiatric sequelae of severe injury: a 6-year follow-up studyO'Donnell, M.; Alkemade, N.; Creamer, M.; McFarlane, A.; Silove, D.; Bryant, R.; Forbes, D.
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.